27
REFERENCES

REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

Embed Size (px)

Citation preview

Page 1: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFERENCES

Page 2: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

9. REFERENCES

Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein LA and

Ortmann B (2002) Regulation of the expression of mouse TAP-associated

glycoprotein (tapasin) by cytokines. Immunol. Lett., 83: 197-207.

Abdollahi A, Lord KA, Roffman-Liebermann B and Liebermann D (1991) IRF-1

is a myeloid differentiation primary response gene induced by IL-6 and leukemia

inhibitory factor: role in growth inhibition. Cell growth differ., 2: 401-407.

Akira S, Uematsu S and Takeuchi 0 (2006) Pathogen recognition and innate

immunity. Cell. 124: 783-801

Au WC, Moore PA, LaFleur DW, Tombal B, and Pitha PM (1998)

Characterization of the interferon regulatory factor-7, and its potential role in the

transcription activation of interferon A genes. J. Bioi. Chern. 273, 29210.

Au WC, Moore PA, Lowther W, Juang YT, and Pitha PM (1995) Identification of

a member of the interferon regulatory factor family that binds to the interferon­

stimulated response element and activates expression of interferon- induced genes.

Proc. Natl. Acad. Sci. USA 92, 11657.

Au WC, Yeow WS and Pitha PM (2001) Analysis of functional domains of

interferon regulatory factor 7 and its association with IRF-3. Virology 280 (2):

273-287

Aziz, F., van Wijnen, A. J., Stein, J. L. and Stein, G. S. (1998). HiNF-D (CDP­

cut/CDC2/cyclin A/pRB-complex) influences the timing of IRF-2-dependent cell

cycle activation of human histone H4 gene transcription at the G liS phase

transition. J Cell Physiol. 177(3):453-464.

Aziz, F., van Wijnen, A. J., Vaughan, P. S., Wu, S., Shakoori, A. R., Lian, J. B.,

Soprano, K. J., Stein, J. L. and Stein, G. S. (1998). The integrated activities of

IRF-2 (HiNF-M), CDP/cut (HiNF-D) and H4TF-2 (HiNF-P) regulate transcription

101

Page 3: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

of a cell cycle controlled human histone H4 gene: mechanistic differences

between distinct H4 genes. Mol Bioi Rep. 25(1):1-12.

Barnes B, and Pitha M (2002) On the role of IRF in host defense. JICR., 22, 59-71

Battistini A, Marsili G, Sgarbanti M, Ensoli B, Hiscott J. (2002). IRF

regulation of HIV -1 long terminal repeat activity. J. Inteiferon Cytokine Res.

22(1):27-37. Review.

Behera AK, Kumar M, Lockey RF, Mohapatra SS. (2002). 2'-5' Oligoadenylate

synthetase plays a critical role in interferon-gamma inhibition of respiratory

syncytial virus infection of human epithelial cells. J. Bioi. Chem.

277(28):25601-8.

Birnbaum, M. J., Zundert, B., Vaughan ,P. S., Whitmarsh, A. J., van, Wijnen, A.

J., Davis, R. J., Stein, G. S. and Stein, J. L. (1997). Phosphorylation of the

oncogenic transcription factor interferon regulatory factor 2 (IRF2) in vitro and in

vivo. J Cell Biochem. 66(2): 175-183.

Blanco JC, Contursi C, Salkowski CA, DeWitt DL, Ozato K, Vogel SN.

(2000). Jun.Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon

gamma-dependent cyclooxygenase 2 expression. J. Exp. Med. 191(12):2131-

44.

Blanco, C., Salkowski, C. A., DeWitt, D. L., Ozato. and Vogel, K. (2000).

Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma­

dependent cyclooxygenase 2 expression. J. Exp. Med. 191(12):2131-2144.

Bovolenta, C., Driggers, P, H., Marks, M, S., Medin, J, A., Politis, A,D., Vogel, S,

N., Levy, D, E., Sakaguchi, K.,Appella, E. and Coligan, J, E.(1994) Molecular

interactions between interferon consensus sequence binding protein and members

of the interferon regulatory factor family. Proc. Natl.Acad. Sci. U S A.

91(11):5046-5050.

Page 4: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Burysek L, Pitha PM. (2001) Mar.Latently expressed human herpesvirus 8-

encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated

protein kinase. J. Virol.;15(5):2345-52.

Burysek L, Yeow WS, Lubyova B, Kellum M, Schafer SL, Huang YQ, Pitha

PM. (1999). Sep. Functional analysis of human herpesvirus 8-encoded viral

interferon regulatory factor 1 and its association with cellular interferon

regulatory factors and p300. J. Virol. 73(9): 7334-42.

Burysek L, Yeow WS, Pitha PM. (1999). Unique properties of a second human

herpesvirus 8-encoded interferon regulatory factor (viRF-2). J. Hum.

Virol. ;2( 1 ): 19-32.

Chen L, Glover JNM, Hogan PG, Rao A and Harrison SC (1998) Structure of

the DNA binding domains from NFAT, Fos and Jun bound specifically to

DNA. Nature. 392: 42-48.

Childs KS and Goodboum S. (2003) Identification of novel co-repressor

molecules for Interferon Regulatory Factor-2. Nucleic Acids Res. 31(12): 3016-

26.

Choi Y, Johnson GA, Burghardt RC, Berghman LR, Joyce MM, Taylor KM,

Stewart MD, Bazer FW, Spencer TE. (2001). Interferon regulatory factor-two

restricts expression of interferon-stimulated genes to the endometrial stroma

and glandular epithelium of the ovine uterus. Biol Reprod.; 65(4):1038-49.

Chow WA, Fang JJ, Yee JK.(2000). The IFN regulatory factor family

participates in regulation of Fas ligand gene expression in T cells. J. Immunol.

164(7):3512-8.

Coccia EM, Del Russo N, Stellacci E, Orsatti R, Benedetti E, Marziali

G,Hiscott J, Battistini A.(1999). Activation and repression of the 2'-5'A

synthetase and p21 gene promoters by IRF-1 and IRF-2. Oncogene.

18(12):2129-37.

103

Page 5: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Coccia EM, Stellacci E, Valtieri M, Masella B, Feccia T, Marziali G, Hiscott J,

Testa U, Peschle C, Battistini A.(2001). Ectopic expression of interferon

regulatory factor-1 potentiates granulocytic differentiation. Biochem J.

360(2):285-94.

Cohen Land Hiscott J (1992) Characterization of TH3, an induction-specific

protein interacting with the interferon beta promoter. Virology. 191(2): 589-99.

Cuesta N, Salkowski CA, Thomas KE, Vogel SN. (2003). Regulation of

lipopolysaccharide sensitivity by IFN regulatory factor-2. J. Immunol. 170(11):

5739-47.

Cunningham C, Barnard S, Blackboum DJ, and Davison AJ (2003)

Transcription mapping of Human herpes virus 8 genes encoding viral

interferon regulatory factors. J. Gen. Virol., 84: 1471-1483.

Darnell, J. E., Kerr, I. M. and Stark G. R. (1994). JAK-STAT pathways and

transcriptional activation in response to IFNs and other extracellular singling

proteins. Science 264:1415-1421.

Doherty GM, Boucher L, Sorenson K, Lowney J. (2001). Interferon regulatory

factor expression in human breast cancer. Ann Surg. 233(5): 623-9.

Drew PD, Franzoso G, Becker KG, Bours V, Carlson LM and Ozato K (1995)

NFKB and IRF-1 physically interact and synergistically induce maJor

histocompatibility class I gene expression. 1./.C.R., 15:1037-1047.

Dror 0, Nussinov Rand Wolfson HJ (2006) The ART web server for aligning

RNA tertiary structures. Nucleic Acid Res., 34: W412-W415.

Duncan GS, Mittrucker HW, Kagi D, Matsuyama T and Mak TW (1996) The

transcription factor IRF-1 is essential for NK cell function in vivo. J.EXP.

Med., 184: 2043-2048.

1011

Page 6: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Du MX, Sotero-Esteva WD and Taylor MW (2000) Analysis of transcription

factors regulating induction of indoleamine 2,3-dioxygenase by IFN-gamma. J

Inteiferon Cytokine Res. 20(2): 133-42.

Elser B, Lohoff M, Kock S, Giaisi M, Kirchhoff S, Krammer PH, Li-Weber M.

(2002). dec.IFN-gamma represses IL-4 expression via IRF-1 and IRF-2.

Immunity. 17(6):703-12.

Escalante, C. R.,Yie, J., Aggarwal, A. K. and Thonos, D. (1998). Structure of IRF-

1 with bound DNA reveals determinants of IFN regulation. Nature. 391:103-106.

Eisenbeis CF, singh H and storb U (1995) Pip, a novel IRF family member, is a

lymphoid specific , PU.1 -dependent transcriptional activator. Genes Dev., 9:

1377-1387.

Falvo JV, Parekh BS, LinCH, Fraenkel E, Maniatis T. (2000). Assembly of a

functional beta interferon enhanceosome is dependent on ATF-2-c-jun

heterodimer orientation. Mol Cell Bioi. 20(13):4814-25.

Fan, C, M., and Maniatis, T.(1989) Two different virus inducible elements are

required for human IFN gene regulation. EMBO J. 8:101-110.

Fehr T, Schoedon G, Odermatt B, Holtschke T, Schneemann M, Bachmann MF,

Mak TW, Horak I and Zinkemagel RM (1997) Crucial role of interferon

consensus sequence binding protein, but neither of interferon regulatory factor 1

nor of nitric oxide synthesis for protection against murine listeriosis. J. Exp. Med.

185: 921-31

Feng X, Petraglia AL, Chen M, Byskosh PV, Boos MD, Reder AT. (2002).

Low expression of interferon-stimulated genes in active multiple sclerosis

islinked to subnormal phosphorylation of STAT!. J Neuroimmunol. 129(1-2):

205-15.

]()"

Page 7: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Flowers CC, Flowers SP and Nabel GJ (1998) Kaposi's Sarcoma-associated

herpes virus viral IRF confers resistance to the antiproliferative effect of

interferon alpha. Mol. Med. 4: 402-4012

Fuji, Y.1999.Crystal Structure of an IRF-DNA Complex Reveals Novel DNA

Recognition and Cooperative Binding to a Tandem Repeat of Core Sequence,

EMBO J., 18, pp.5028 .

Furui J, Uegaki K, Yamazaki T, Shirakawa M, Swindells MB, Harada H,

Taniguchi T, Kyogoku Y. (1998) Solut!on structure of the IRF-2 DNA-binding

domain: a novel subgroup of the winged helix-tum-helix family. Structure. 6(4):

491-500.

Fujii Y, Shimizu T, Kusumoto M, Kyogoku Y, Taniguchi T, Hakoshima T.

(1999). Crystal structure of an IRF-DNA complex reveals novel DNA

recognition and cooperative binding to a tandem repeat of core sequences.

EMBO J. 18(18): 5028-41.

Fujii, Y., Shimizu, T., Kusumoto, M., Kyogoku, Y., Taniguchi, T. and

Hakoshima, T. (1999) Crystal structure of an IRF-DNA complex reveals novel

DNA recognition and cooperative binding to a tandem repeat of core sequences.

EMBO J 18(18):5028-5041.

Fujita T, Sakakibara J, Sudo Y, Miyamoto M, Kimura Y and Taniguchi T (1998)

Evidence of a nuclear factor(s), IRF-1, mediating induction and silencing

properties to human IFN-~ gene regulatory elements. EMBO J., 7: 3397-4505.

Fujita, T. Kimura, Y., Miyamoto, M. and Taniguchi, T. (1989) Induction of

endogenous IFNa and IFN~ genes by a regulatory transcription factors IRF-1.

Nature. 337:270-272.

106

Page 8: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Gao SJ, Boshoff C, Jayachandra S, Weiss RA, Chang Y and Moore PS (1997)

KSHV ORF K9 (viRF) is an oncogene which inhibits the interferon signaling

pathway. Oncogene 15: 1979-1985.

Glover JNM and Harrison SC (1995) Crystal structure of the heterodimeric bZIP

transcription factor c-Fos-c-Jun bound to DNA. Nature, 373:257-261

Goodwin BL, Xi H, Tejiram R, Eason DD, Ghosh N, Wright KL, Nagarajan U,

Boss JM, Blanck G. (2001). Varying functions of specific major

histocompatibility class II transactivator promoter III and IV elements in

melanoma cell lines. Cell Growth Differentiation. 12(6): 327-35.

Greenlund AC, Morales MO, Viviano BL, Yan H, Krolewski J, and Schreiber

RD (1995) Stat recruitment by tyrosine phosphorylated cytokine receptors: an

ordered reversible affinity-driven process. Immunity 2: 677-87

Grieder FB, Vogel SN (1999) Role of interferon and interferon regulatory

factors in early protection against Venezuelan equine encephalitis virus

infection. Virology. 257(1): 106-18.

Guillemard E, Varano B, Belardelli F, Quero AM, Gessani S. (1999).

Inhibitory activity of constitutive nitric oxide on the expression of alpha/beta

interferon genes in murine peritoneal macrophages. J Viral. 73(9):7328-33.

Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T

and Taniguchi T. (1989) Structurally similar but functionally distinct factors, IRF-

1 and IRF-2, bind to the same regulatory elements of IFN and /FN-inducible

genes. Cell. 58( 4 ): 729-739.

Harada H, Willison K, Sakakibara J, Miyamoto M, Fujita T and Taniguchi T

( 1990) Absence of type IFN system in EC cells: transcriptional activator, (IRF-1)

and repressor (IRF-2) genes are developmentally regulated. Cell, 63: 903-913.

107

Page 9: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M,

Taniguchi T. (1993) Anti-oncogenic and oncogenic potentials of interferon

regulatory factors-1 and -2.Science. 259( 5097):971-97 4.

Harada H, Takahashi E, ltoh S, Harada K, Hori TA and Taniguchi T (1994)

Structure and regulation of the human IRF-1 and IRF-2 genes: implications for a

gene network in the IFN system. Mol. Cell. Biol., 14: 1500-9

Harada H, Matsumoto, Sato M, Kashiwazaki Y, Kimura T, Kitagawa M, Yokochi

T, Sok-PinTan R, Takasugi T, Kadokawa Y, Schindler C, Schreiber RD, Noguchi

S, and Taniguchi T (1996) Regulation of IFN-a/a genes: evidence for a dual

function of the transcription factor complex ISGF3 in the production and action of

IFN-a/a. Genes cell, 1: 115-124.

Harada H, Taniguchi T and Tanaka N (1998) The role of interferon regulatory

factors in the interferon system and cell growth control. Biochimie. 80(8-9): 641-

50. Review.

Hida S, Ogasawara K, Sato K, Abe M, Takayanagi H, Yokochi T, Sato T,

Hirose S, Shirai T, Taki S, Taniguchi T. (2000). CD8(+) T cell-mediated skin

disease in mice lacking IRF-2, the transcriptional attenuator of interferon­

alpha/beta signaling./mmunity. 13(5): na643-55.

Hiscott J, Pitha P, Genin P, Nguyen H, Heylbroeck C, Mamane Y, Algarte M, Lin

R. 1999.Triggering the interferon response: the role of IRF-3 transcription factor.

J. Interferon Cytokine Res., 19: 1-14.

Holtschke T, Lohler J, Kanno Y, Fehr T, Giese N, Rousenbauer F, Lou J,

Knobeloch KP, Gabriele L, waring JF, Bachmann MF, Zinkemagel RM, Morse

HC 3rd, Ozato K and Horak (1996) Immunodeficiency and chronic myelogenous

leukiemia-like syndrome in mice with a targeted mutation of the ICSBP gene.

Cell. 87: 307-317.

108

Page 10: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Honda K, Mizutani T and Taniguchi T (2004) Negative regulation of IFN­

alpha/beta signaling by IFN regulatory factor-2 for homeostatic development of

dendritic cells. PNAS USA., 101, 2416-24121.

Honda K, Yanai H, Negishi H, Asagiri M, Sato T, Mizutani T, Shimada N, Ohba

Y, Takoka A, Yoshida N and Tanighuchi T (2005) IRF-7 is the master regulator

of type -1 interferon -dependent immune responses. Nature, 434, 772-777.

Honda K, Takaoka A and Taniguchi T (2006) Type I Interferon gene induction by

IRF family of transcription factors. Immunity 25: 349-360.

Hu G and Barnes BJ (2006) IRF-5-regulated pathways as a target for colorectal

cancer therapeutics. Expert Rev. Anticancer Ther., 6: 775-784.

Huth JR, Bewely CA, Nissen MS, Evans JNS, Reeves R, Gronenbom AM and

Clore GM (1997) The solution structure of an HMG-I(Y)-DNA complex defines a

new architectural minor groove binding motif. Nature struct. Bioi., 4: 657-665.

lhle JN and Kerr IM ( 1995) J aks and Stats in signaling by the cytokine receptor

superfamily. Trends Genet., 11: 69-74.

Improta T, Schindler C, Horvath CM, Kerr IM, Stark GR, and Jr. Darnel JE

(1994) Transcription factor ISGF3 formation requires phosphorylated Sat91

protein, but Stat 113 protein is phosphorylated independently of Stat91 protein.

PNAS, USA., 91: 4776-4780

Ingraham CR, Kinoshita A, Kondo S, Yang B, Sajan S, Trout KJ, Malik MI,

.Dunnwald M, Goudy S.L., Lovett M, Murray JC and Schutte BC (2006)

Abnormal skin, limb, and craniofacial morphogenesis in mice deficient for IRF-6.

Nat. Genet., 38: 1335-1340.

Itoh, S., Harada, H., Fujita, T., Mimura, T. and Taniguchi, T. (1989) Nucleotide,

Protein Sequence of a eDNA coding for human IRF-2. Nucleic Acids Res.

17(20):8372.

!(\(\

Page 11: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Iwase S, Furukawa Y, Kikuchi J, Saito S, Nakamura M, Nakayama R,

Horiguchi-Yamada J, Yamada H. (1999). Defective binding of IRFs to the

initiator element of interleuk:in-1 beta-converting enzyme (ICE) promoter in an

interferon-resistant Daudi sub line. FEBS Lett. 450(3): 263-7.

Jarosinski KW and Massa PT (2002) IRF-1 is required for IFN-y-induced

MHC class I genes in astrocytes. J. Neuroimmunol., 122: 74-84.

Jesse, T. L., Lachance, Rand Ladermann, M. F.(1998) IRF-2 is a transcriptional

activator inmuscle where it regulates expression of Vascular and Cell Adhesion

Molecule-1(VCAM-1). J.Cell.Biol140:1265-76.

Jenner RG, Alba MM, Boshoff C and P. Kellam (2001) Kaposi's sarcoma­

associated herpes virus latent and lytic gene expression as revealed by DNA

arrays. J. Virol., 75:891-902

Johnson GA, Joyce MM, Yankey SJ, Hansen TR, Ott TL. (2002). The

Interferon Stimulated Genes (ISG) 17 and Mx have different temporal and

spatial expression in the ovine uterus suggesting more complex regulation of

the Mx gene. J Endocrinol. 174(2):R7-R11.

Juang YT, Lowther W, Kellum M, Au WC, Lin R, Hiscott J, Pitha

PM.1998.Primary activation of IFNa and IFN§ gene expression by IRF-3. Proc.

Nat. Acad. Sci. 95: 9837-9842.

Juang, Y.-T., Lowther, W., Kellum, M., Au, W.-C., Lin, R., Hiscott, J., and Pitha,

P.M. 1998.Primary activation of interferon A and interferon B gene transcription

by interferon regulatory factor 3. Proc. Natl. Acad. Sci. USA 95, 9837.

Kamijo R, Harada H and Matamyame, T (1994) Requirement for transcription

factor IRF-1 in Nitric oxide synthetase induction in Macrophages. Science

263:1612-1615.

110

Page 12: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Keller AD and Maniatis T ( 1991) Identification and characterization of a novel

repressor of ~-IFN gene expression. Genes Dev., 5: 868-879.

Kim EJ, Lee JM, Narnkoong SE, Urn SJ, Park JS. (2002). Interferon regulatory

factor-1 mediates interferon-gamma-induced apoptosis in ovarian carcinoma

cells. J. Cell. Biochern. 85(2): 369-80.

Kim T, Kim TY, Song YH, Min I.M, Yim J, and Kim TK (1999) Activation of

IRF3 in response to DNA damaging agents. J. Bioi. Chern. 274: 30686.

Kim EJ, Park CH, Park JS and Urn SJ (2003) Functional dissection of the

transactivation domain of IRF-1. B.B.R. C., 304:253-259

Kraus T A, Lau JF, Parisien JP and Horvath CM (2003) A hybrid IRF9-ST A T2

protein recapitulates interferon-stimulated gene expression and antiviral response.

J. Biol. Chern., 278: 13033-13038.

Kimura T, Nakayama K, Penninger J, Kitagawa M, Harada H, Matsuyama T,

Tanka N, Kamijo Ret. a/.,(1994) Involvement of the IRF-1 transcription factor in

antiviral responses to interferons. Science, 264, 1921-1924.

Kimura T, Kadokawa Y, Harada H, Matsumoto M, Sato M, Kashiwazaki Y,

Tarutani M, Tan RS, Tkasugi T, Matsuyama T, Mak TW, Noguchi S and

Taniguchi T (1996) Essential and non-redundant role of p48(1SFG3y) and IRF-1

in both type I and type II interferon responses, as revealed by gene targeting

studies. Gene Cells, 1: 115-124.

Kirchhoff S, Oumard A, Nourbakhsh M, Levi BZ, Hauser H. (2000). Interplay

between repressing and activating domains defines the transcriptional activity

of IRF-1. Eur J Biochern. 267(23): 6753-61.

Ill

Page 13: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Kyte J and Doolittle RF (1992) A simple method for displaying the

hydropathic character of a protein. 1.Mol. Biol., 157: 105-132

Ko J, Gendron-Fitzpatrick A, Splitter GA. (2002). Susceptibility of IFN

regulatory factor-1 and IFN consensus sequence binding protein-deficient mice

to brucellosis. 1 Immunol.168(5):2433-40.

Kondo S, Schutte BC, Richardson RJ, Bjork BC, Knight AS, Watanabe Y,

Howard E, de Lima RL, et. al., (2002) Mutations in IRF6 cause Van der

Woude and popliteal pterygium syndromes. Nat. Genet., 32: 285-289.

Koenig Merediz SA, Schmidt M, Hoppe GJ, Alfken J, Meraro D, Levi BZ,

Neubauer A, Wittig B. (2000). Cloning of an interferon regulatory factor 2

isoform with different regulatory ability. Nucleic Acids Res. 28(21): 4219-24.

Kroger, A., Koster, M., Schroeder, K., and Mueller, P.P.(2002) Activities of IRF-

1 . 1./.C.R. 22:5-14.

Kroger A, OrtmannD, Krohne TU, Mohr L, Blum HE, Hauser and Geissler M

(2001) Growth suppression of the hepatocellular carcinoma cell line Hepal-6 by

an activable IRF-1 in mice. Cancer Res., 61, 2601-2617.

Kuo TC and Calame KL (2004) B lymphocyte-induced maturation protein

(Blimp )-1, IFN regulatory factor (IRF)-1, and IRF-2 can bind to the same

regulatory sites. 1 Immunol., 73(9): 5556-63.

Lechleitner, S., Gille, J., Johnson, D.R. and Petzelbauer, P. (1998) Interferon

enhances tumor necrosis factor-induced vascular cell adhesion molecule 1

(CD106) expression in human endothelial cells by an interferon-related factor 1-

dependent pathway. 1 Exp Med. 187(12):2023-2030.

Lee PT, Holt PG, McWilliam AS. (2001). Failure of MHC class II expression

in neonatal alveolar macrophages: potential role of class II transactivator. Eur 1

Immunol. 31(8): 2347-56.

112

Page 14: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Li W, Nagineni CN, Efiok B, Chepelinsky AB, Egwuagu CE. (1999).

Interferon regulatory transcription factors are constitutively expressed and

spatially regulated in the mouse lens. Dev Bioi. 210(1): 44-55.

Li W, Nagineni CN, Hooks JJ, Chepelinsky AB, Egwuagu CE. (1999).

Interferon-gamma signaling in human retinal pigment epithelial cells mediated

by ST AT1, ICSBP, and IRF-1 transcription factors. Invest Ophthalmol Vis Sci.

40(5): 976-82.

Lin R, Heylbroeck C, Genin P, Pitha PM, Hiscott J (1999) Essential role of IRF-3

in direct activation of RANT'SS gene transcription. Mol Cell Bioi. 19: 959-966.

Lin R, Heylbroeck C, Pitha PM, Hiscott J (1998) Virus dependent

phosphorylation of the IRF-3 transcription factor regulates nuclear translocation,

transactivation potential and proteasome-mediated degradation. Mol. Cell. Bioi.

18: 2986-2996.

Lin RT, Mamane Y, Hiscott J (1999) Structural and functional analysis of

interferonregulatory factor 3: localization of the transactivation and autoinhibitory

domains Molecular and cellular biology 19(4): 2465-2474

Lin R. and Hiscott J ( 1999) A role of casein kinase II phosphorylation in the

regulation of IRF-1 transcriptional activity. Mol.Cell.Biochem.191: 169-180.

Liu J, Guan X, Tamura T, Ozato K and MaX (2004) Synergistic activation of IL-

12p35 gene transcription by IRF-1 and ICSBP. 1. Bioi. Chem., 279: 55609-55617.

Lohoff M, Ferrick D, Mittrucker HW, Duncan GS, Bischof S, Rollinghoff M and

Mak TW(1997) Interferon regulatory factor-1 is required for aT helper 1 immune

response in vivo. Immunity 6:681- 89.

Lohoff, M., Duncan, G. S., Ferrick, D., Mittrucker, H, W., Bischof, S., Prechtl, S.,

Rollinghoff, M., Schmitt, E., Pahl, A. and Mak, T. W. (2000).

113

Page 15: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Deficiency in the transcription factor interferon regulatory factor (IRF)-2

leads to severely compromised development of natural killer and T helper

type 1 cells. J Exp Med. 192(3):325-336

Lowney JK, Boucher LD, Swanson PE, Doherty GM. (1999). Interferon

regulatory factor-1 and -2 expression in human melanoma specimens. Ann Surg

Oncol. 6(6):604-8.

Lu, R., and Pitha, P.M. (2001) Monocyte differentiation to macrophase requires

interferon regulatory factor 7, J. Bioi. Chern., 276.

Lubyova B, Kellum MJ, Frisancho AJ and Pitha PM (2004) Kaposi's sarcoma

associated herpesvirus-encodedviRF-3 stimulates the transcriptional activity of

cellular IRF-3and IRF-7. J. Bioi. Chern., 279: 7643-7654

Lubyova B and Pitha PM (2000) Characterization of a novel human herpes virus

8-encoded protein, viRF-3, that shows homology to viral and cellular IRFs. J.

Virol., 74: 8194-8201.

Mancl ME, HuG, Sangster-Guity N, Olshalsky SL, Hoops K, Fitzgerald-Bocarsly

P, Pitha PM, Pinder K and Barnes BJ (2005) Two discrete promoters regulate the

alternatively spliced human IRF-5 isoforms. Multiple isoforms with distinct cell

type-specific expression, localization, regulation and function. J. Bioi. Chern.,

280: 21078-21090.

Meraro D, Hashmueli S, Koren B, Azriel A, Oumard A, Krichhoff S, Hauser H,

Nagulapalli S, Atchison ML and Levi BZ (1999) Protein -protein and DNA

protein interactions affect the activity of lymphoid specific IFN Regulatory

Factors. J. Irnrnuno/.163: 6468-6478.

Meraro D, Gleit-Kielmanowicz M, Hauser H, and Levi BZ (2002) IFN stimulated

gene 15 is synergistically activated through interactions between the

myelocyte/lymphocyte-specific transcription factors, PU .1, IRF-8/ICSBP, and

114

Page 16: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

IRF-4: characterization of a new subtype of IFN-stimulated response element. J.

Immunol., 168: 6224-6231

Mittrucker HW, Matsuyama T, Grossman A, Kudig TM, Potter J, Shahinian A,

Wakeham A, Patterson B, Ohashi PS and Mak TW (1997) Requirement of

transcription factor LSIRF/IRF-4 for mature B and T lymphocyte function.

Science, 275, 540-543.

Mamane, Y., Heylbroeck, C., Genin, P., Algarte, M., Servant, M. 1., DeLuca, C.,

K won, H. and Lin, R. (1999) Hiscott J .Interferon regulatory factors: the next

generation. Gene. 237(1):1-14. Review.

MacDonald NJ, Kuhl D, Maguire D, Naf D, Gallant P, Goswamy A, HugH,

Bueler H, Chatruvedi M, Fuente JDL, Ruffner, H, Meyer F and weissmann C

(1990) Different pathways Mediate Virus Inducibility of the Human IFN-a1 and

IFN-~ genes. Cell. 60: 767-779.

Manzella L, Gualdi R, Perrotti D, Nicolaides NC, Girlando G, Giuffrida MA,

Messina A, Calabretta B. (2000). The interferon regulatory factors 1 and 2 bind

to a segment of the human c-myb first intron: possible role in the regulation of

c-myb expression. Exp Cell Res. 256(1): 248-56.

Marecki S, Atichson ML and Fenton MJ (1999) Differential expression and

Distinct functions of IRF-4 and ICSBP in macrophages. J. lmmunol., 163:

2713-2722

Marecki S, Riendeau CJ, Liang MD, Fenton MJ. (2001). PU.l and multiple

IFN regulatory factor proteins synergize to mediate transcriptional activation of

the human IL-l beta gene. 1 Immunol. 166(11): 6829-38.

Marie I, Durbin JE and Levy DE (1998) Differential viral induction of distinct

IFN-a genes by positive feedback through IRF-7. EMBO 1., 17: 6660-6669

115

Page 17: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Massa PT, Whitney LW, Wu C, Ropka SL, Jarosinski KW. (1999). A

mechanism for selective induction of 2'-5' oligoadenylatesynthetase,anti-viral

state, but not MHC class I genes by interferon-beta in neurons. J Neurovirol.

5(2): 161-71.

Masumi A, Wang IM, Lefebvre B, Yang XJ, Nakatani Y and Ozato K (1999)

The histone acetylase PCAF is a phorbol-ester-inducible coactivator of the IRF

family that confers enhanced interferon responsiveness. Mol Cell Bioi. 19(3):

1810-20.

Masumi A, Ozato K. (2001). Coactivator p300 acetylates the interferon

regulatory factor-2 in U937 cells following phorbol ester treatment. J Bioi

Chern. 276(24): 20973-80. Epub.

Masumi A, Yamakawa Y, Fukazawa H, Ozato K, Komuro K. (2003).

Interferon regulatory factor-2 regulates cell growth through its acetylation .. J.

Bioi Chern. [Epub ahead of print]

Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N,

Kudig TM, Amakawa R, Kishihara K, Wakeham A et. al. (1993) Targeted

disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction

and abberent lymphocyte development. Cell, 75, 83-97.

Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan

DH, Riley JK, Greenlund AC, Campbell D and Schreiber RD (1996)

Targeted disruption of the Stat1 gene results in compromised innate immunity

to viral disease. Cell, 84: 431-42

Miyamoto M, Fujita T, Kimura Y, Maruyama M, Harada H, Sudo Y, Miyata

T and Taniguchi T (1988) Regulated expression of a gene encoding a nuclear

factor, IRF-1, that specifically binds to IFN-~ gene regulatory elements. Cell,

54: 903-913.

116

Page 18: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Moore PS and Chang Y (1998) Antiviral activity of tumor-suppressor

pathways: clues from molecular piracy by KSHV. Trends Genet., 14: 144-150.

Mostowska A, Wojcicki P, Kobus K, and Trzeciak WH (2005) Gene symbol:

IRF-6. Disease: VanderWoude syndrome. Hum. Genet., 116: 534

Mori T, Anazawa Y, Liizumi M, Fukuda S, Nakamura Y and Arakawa H

(2002) Identification of the IRF-5 as a direct target for p53. Oncogene 21:

2914-2918.

Munshi N, Yie Y, Merika M, Senger K, Lomvardas S, Agalioti T and Thanos

D (1999) The IFN-13 enhancer: a paradigm for understanding activation and

repression of individual gene expression. Cold Spring Harb. Symp. Quant.

Bioi. 64, 149-159.

Munshi N, Agalioti T, Lomvardas S, Merika M, ChenG and Thanos D (2001).

Coordination of a transcriptional switch by HMGI(Y) acetylation. Science 293,

1133-1136.

Nehyba J, Hrdlickova R, Burnside J and Bose HR Jr. (2002) A novel IRF, IRF-

10, has a unique role in immune defense and is induced by the V -rei

oncoprotein. Mol. Cell. Boil., 22:3942-3957

Nguyen H., Hiscott J. and Pitha P.M.( 1997) The growing family of interferon

regulatory factors. Cytokine Growth Factor Rev. 8(4):293-312. Review.

Nishio Y., Noguchi E., Ito S., Ichikawa E., Umebayashi Y., Otsuka F. and

Arinami T. (2001) Mutation and association analysis of the interferon regulatory

factor 2 gene (IRF2) with atopic dermatitis. 1 Hum Genet. 46( 11 ): 664-7.

Nishihira J (1993) Identification and chararcterization of hydrophobic ligand

binding region in glutathione S-transferase P. Hokkaido IgakuZasshi [article in

Japanese] 68: 54-64.

Page 19: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Nonkwelo C, Ruf IK, and sample J (1997) Interferon dependent and induced

regulation of Epstein-Barr Virus EBNA-1gene transcription in Burkitt lymphoma.

J. Virol. 71: 6887-6897.

Nonkwelo, C., Ruf, I. K. and Sample, J. (1997) Interferon-independent and

induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt

lymphoma. J Virol.71(9):6887-97.

Oberg K. (2000). Interferon in the management of neuroendocrine GEP-tumors: a

review. Digestion.;62 Suppl1:92-7. Review.

Panne D, Maniatis T and Harrison SC (2007) An atomic model of the interferon -

beta Enhanceosome. Cell 129, 1111-1123.

Palombella VJ and Maniatis T (1992) Inducible processing of interferon

regulatory factor-2. Mol Cell Biol. 12(8): 3325-36.

Passioura T, Shen S, Symonds G and Dolnikov A (2005) A retroviral library

genetic screen identifies IRF-2 as an inhibitor of N-ras-induced growth

suppression in leukemic cells. Oncogene. 24(49): 7327-36.

Pelletier H, and Sawaya MR (1996) Characteization of the metal ion binding

helix-hairpin-helix motifs in human DNA polymerase ~ complexed with DNA:

implications for catalytic mechanism, processivity and fidelity. Biochemistry. 35:

12742-12761.

Penninger JM, Sirard C, Mittrucker HW, Hakem A, Kimura T, Taniguchi T and

Mak TW ( 1997) the IRF-1 controls positive and negative selection of CDS+

thymocytes. Immunity, 7: 243-254.

118

Page 20: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Pine R, Canova A and Schindler C ( 1994) Tyrosine phosphorylated p91 binds to

a single element in the ISGF2/IRF-1 promoter to mediate induction by IFNa and

IFNy, and is likely to autoregulate the p91 gene. EMBO J., 13:158-67

PineR (2002) IRF and tuberculosis. J.l.C.R., 22: 15-25.

Politis AD, Sivo J, Driggers PH, Ozato K and Vogel SN (1992) Modulation of

ICSBP rnRNA in murine peritoneal macrophages. Induction by IFNy and down­

regulation by IFN-a, dexamethasone, and protein kinase inhibitors. J. Immunol.,

148: 801-807.

Reis LFL, Harada H, Wolchok JD, Taniguchi T and Vilcek J (1992) Critical role

of common transcription factor, IRF-, in the regulation of IFN and IFN -inducible

genes. EMBO 1.,11, 185-193.

Reis LF, Ruffner G, Stark G, Aguet M and Weissmann C (1994) Mice devoid of

IRF-1 show normal expression of type I IFN genes. EMBO J., 13, 4798-4806.

Richardson RJ, Dixon J, Malhotra S, Hardman MJ, Knowles L, Boot-Handford

RP, Shore P, Withmarsh A and Dixon MJ (2006) IRF-6 is a key determinant of

the keratinocytes proliferation -differentiation switch. Nat. Genet., 38: 1329-1334.

Rivas C, Thlick AE, Parravicini C, Moore PS and Chang Y (2001) Kaposi's

sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein

that inhibits p53. J. Viral., 75:429-438

Ronco LV, Karpova AY, Vidal M and Howley PM (1998) Human papillomavirus

16 E6 oncoprotein binds to IRF-3 and inhibits its transcriptional activity. Genes

Dev. 12: 2061-2072

Rouyez MC, Lestingi M, Charon M, Fichelson S, Buzyn A and Dusanter-Fourt I.

119

Page 21: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

(2005) IFN regulatory factor-2 cooperates with STATl to regulate transporter

associated with antigen processing-! promoter activity. J Immunol. 174(7): 3948-

58.

Rubinstein YR, Driggers PH, Ogryzko VV, Thornton AM, Ozato K, Pontzer

CH. (2000). Mar.An IFN regulatory factor-2 DNA-binding domain dominant

negative mutant exhibits altered cell growth and gene expression. Oncogene.

19(11): 1411-8.

Salkowski CA, Kopydlowski K, Blanco J, Cody MJ, McNally R, Vogel SN.

(1999). Aug.IL-12 is dysregulated in macrophages from IRF-1 and IRF-2

knockout mice. J Immunol. 163(3): 1529-36.

Saura M, Zaragoza C, Bao C, McMillan A and Lowenstein CJ (1999)

Interaction of IRF-1 and NFKB during inducible nitric oxide synthase

transcription. J. Mol. Bioi., 289: 459-471.

Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T,

Katsuki M, Noguchi S, Tanaka N and Taniguchi T (2000) Distinct and

essential roles of transcription factors IRF-3 and IRF-7 in response to viruses

for IFN-alpha!beta gene induction. Immunity, 13, 539-548.

Schafer SL, Lin RT, Moore PA, Hiscott J, Pitha PM 1998 Regulation of type I

interferon gene expression by interferon regulatory factor-3. Journal of biological

chemistry 273 (5): 2714-2720.

Samuel CE (2007) Interferons, interferon receptors, signal transducers and

activators of transcription, and interferon regulatory factors. J Bioi Chern. 14;

[Epub ahead of print]

Senger K, Merika M, Agalioti T, Yie J, Escalante CR, ChenG, Aggarwal AK and

Thanos D (2000) Gene repression by coactivator repulsion. Mol Cell., 6( 4):931-7.

120

Page 22: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Shalf R, Azreil A, Lejbkowicz F, Winograd SS, Ehrlich R and Levi BZ (1995)

Functional domain analysis of ICSBP and its association with IRFs. J.Biol. Chern.,

270: 13063-13069.

Shalf R, Meraro D, Azriel A, thornton AM, Ozato K, Petricoin EF, Lamer AC,

Schaper F, Hauser H and Levi BZ (1997) Phopshorylation events modulate the

ability of ICSBP to interact with IRFs and to bind DNA. J. Bioi. Chern., 272:

9785-9792.

Schaper F, Kirchoff S, Posem G, Koster M, Oumard A, Scharf R, Levi BZ and

Hauser H (1998) Functional domains of IRF-1. Biochern. J., 335: 147-157.

Sherry B. (2002). The role of interferon regulatory factors in the cardiac response

to viral infection. Viral Immunol. 15(1):17-28. Review.

Stark GR, Kerr IM, Williams BRG, Silvermann RH and Schreiber RD (1998)

How cells respond to IFNs. Ann.Rev.Biochern. 67: 227--264.

Staal A, Enserink JM, Stein JL, Stein GS, van Wijnen AJ (2000) Molecular

characterization of celtix -1, a bromodomain protein interacting with the

transcription factor interferon regulatory factor 2. J. Cell Physiol. 185(2): 269-79.

Tailor P, Tamura T and Ozato K (2006) IRF family proteins and type I IFN

induction in dendritic cells. Cell Res., 16: 134-140.

Taki S, Sato T, Ogasawara K, Fukuda T, Sato M, Hida S, Suzuki G, Mitsuyama

M, Shin EH, Kojima S, Taniguchi T and Asano Y (1997) Multistage regulation of

Th1-type immune responses by the transcription factor IRF-1. Immunity 6:673-79

Taki S. (2002). Type I interferons and autoimmunity: lessons from the clinic and

from IRF-2-deficient mice. Cytokine Growth Factor Rev. 13(4-5):379-91.

Taki S, Nakajima S, Ichikawa E, Saito T and Hida S (2005) IFN regulatory

Factor-2 deficiency revealed a novel check point critical for the generation of

peripheral NK cells. J. Immunol, 174,6005-6012.

121

Page 23: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Tamura T and Ozato K (2002) ICSBP/IRF-8: its regulatory roles in the

development of myeloid cells. 1./. C.R., 22: 145-152.

Tamura T, Tailor P, Yamaoka K, Kong HJ, Tsujimura H, O'Shea JJ, Singh Hand

Ozato K (2005) IFN regulatory factor-4 and -8 govern dendritic cell subset

development and their functional diversity. J. Immunol., 174, 2573-2581.

Takaoka A, Mitani Y, Suemori H, Sato M, Yokochi T, Noguchi S, Tanaka Nand

Taniguchi T (2000) Cross talk between IFN-y and -a/~ signaling components in

caveolar membrane domains. Science 288: 2357-60.

Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, Kano S, Honda

K, Ohba Y, Mak TW and Taniguchi T (2005) Integral role of IRF-5 in the gene

induction programme activated by Toll-Like receptors. Nature, 434: 243-249.

Tanaka K, Miyamoto H, Harada H, Ishihara M. and Taniguchi, T (1993)

Recognition DNA sequence of IFN Regulatory Factor -1(1RF-1) and IRF-2,

regulator of cell growth and the IFN system. Mol. Cell.Biol.13: 4531-4538.

Tanaka N, Ishihara M and Taniguchi T (1994) Suppression of c-myc or fos-B­

induced cell transformation by the transcription factor IRF-1. Cancer Lett.,

83:191-196

Taniguchi T (1988) Regulation of cytokine gene expression. Annu. Rev. lmmunol.,

6: 439-464.

Taniguchi, T. (1989) Regulation of interferon-beta gene: structure and function of

cis-elements and trans-acting factors. J Interferon Res. 9(6): 633-640. Review.

Taniguchi T (1995) Cytokine signaling through non receptor protein tyrosine

kinases. Science, 268: 251-55.

1??

Page 24: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Taniguchi T, Tanaka N, Ogasawara K, Taki S, Sato M, Takaoka A (2000)

Transcription factor IRF-1 and its family members in the regulation of host

defense. Cold Spring Harb Symp Quant Bioi. 64:465-72. Review.

Taniguchi, T., Ogasawara, K., Takaoka, A., and Tanaka, N. (2001) IRF family of

transcription factors as regulators of host defense. Annu Rev Immunol. 19: 623-

655. Review.

Thanos D and Maniatis T (1995) Virus induction of human IFN~ gene requires

the assembly of an enhanceosome. Cell, 83: 1091-1100.

Thayer MM, Aheren H, Xing D, Cunningham RP and Tainer JA (1995) Novel

DNA binding motifs in the DNA repair enzyme endonuclease III crystal structure.

EMBO J., 14:4108-4120.

Toh H, Hayashida H and Miyata T (1983) Sequence homology between

retroviral reverse Transcriptase and putative polymerases of hepatitis B virus

ans Cauliflower mosaic virus. Nature, 305: 827-829.

Vander Fits L, van der WeiLl, Laman JD, Prens EP and Verschuren MC. (2003}.

Psoriatic lesional skin exhibits an aberrant expression pattern of interferon

regulatory factor-2 (IRF-2). J Pathol. 199(1): 107-14.

Vaughan PS, Aziz F, van Wijnen AJ, Wu S, Harada H, Taniguchi T, Soprano KJ,

Stein JL and Stein GS (1995) Activation of a cell-cycle-regulated histone gene

by the oncogenic transcription factor IRF-2. Nature. 377(6547): 362-5

Vaughan PS, Meijden CM., Aziz F., Harada H., Taniguchi T., van Wijnen AJ,

Stein JL and Stein GS (1998) Cell cycle regulation of histone H4 gene

transcription requires the oncogenic factor IRF-2. J.Biol Chern. 273(1): 194-199.

123

Page 25: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Veals C, schindler, Leonard D, Fu XY, Aebersold and Darnell JE Jr. (1992)

Subunit of an alpha-interferon-responsive transcription factor is related to IRF nad

Myb families of DNA-binding proteins. Mol. Cell. Boil., 12: 3315-3324.

Walker J, Crowley P, Moreman AD and Barrett J (1993) Biochemical properties

of cloned glutathione S-transferase from Schistosoma mansoni and Schistosoma

japonicum. Mol. Biochem. Parasitol., 61: 255-264

Wang IM, Blanco JC, Tsai SY, Tsai MJ and Ozato K (1996) Interferon regulatory

factors and TFIIB cooperatively regulate interferon-responsive promoter activity

in vivo and in vitro. Mol Cell Bioi. 16(11): 6313-24.

Wang TN, Chu YT, Chen WY, Feng WW, Shih NH, Hsiang CHand Ko YC

(2006) Association of IFNy and IRF-1 polymorphisms with asthma in a family­

based association study in Taiwan. Clin. Exp. Allergy., 36: 1147-1152.

Watanabe N, Sakakibara J, Hovanessian A, Taniguchi T and Fujita T (1991)

Activation of IFN-~ promoter element by IRF-1 requires a post-translational event

in addition to IRF-1 synthesis. Nucleic Acid Res. 16:4421-28

Weaver BK, Kumar KP and Reich NC (1998) IRF-3 and CREB-binding

proteinlp300 are subunits of ds RNA activated transcription factor DRAFl. Mol.

Cell. Bioi., 18: 1359-68.

White LC, Wright KL, Felix NJ, Ruffner H, Reis LFL, Pine R and Ting JP-Y

(1996) Regulation of LMP2 and T AP1 genes by IRF-1 explains the paucity of

CD8 T cells in IRF-1 mice. Immunity 5:247-53

Willman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, Slovak ML,

Yamamoto H, Harada K, Meeker TC et. al., (1993) Deletion of IRF-1, mapping

to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.

Science, 259: 968-971.

124

Page 26: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

Xi H and Blanck G. (2000). Interferon regulatory factor-2 point mutations in

human pancreatic tumors. Int J Cancer. 87(6): 803-8.

Xie R, van Wijnen AJ, van Der Meijden C, Luong MX, Stein JL and Stein GS

(2001) The cell cycle control element of histone H4 gene transcription is

maximally responsive to interferon regulatory factor pairs IRF-1/IRF-3 and IRF-

1/IRF-7. J Bioi Chem., 276(21): 18624-32.

Xi H, Blanck G. (2003). The IRF-2 DNA binding domain facilitates the activation

of the class II transactivator (CIITA) type IV promoter by IRF-1. Mol Immunol.

39(11): 677-84.

Xi H, Eason DD, Ghosh D, Dovhey S, Wright KL and Blanck G.(1999). Co­

occupancy of the interferon regulatory element of the class II transactivator

(CIITA) type IV promoter by interferon regulatory factors 1 and 2.0ncogene.

18(43): 5889-903.

Xi H, Goodwin B, Shepherd AT and Blanck G. (2001). Impaired class II

transactivator expression in mice lacking interferon regulatory factor-2.

Oncogene. 20(31): 4219-27.

Xie RL, van Wijnen AJ, van der Meijden CM, Stein JL and Stein GS. (2002).

Forced expression of the interferon regulatory factor 2 oncoprotein causes

polyploidy and cell death in FDC-P1 myeloid hematopoietic progenitor cells.

Cancer Res. 62(9): 2510-5.

Yamamoto, H.,Lauphier, M, S., Taniguchi, T. and Harada, H.(1994) . The

oncogenic transcription factor IRF-2 posses a transcriptional repression and a

activation domain. Oncogene. 9: 1423-1428.

Yan H, Krishnan K, Greenlund AC, Gupta S, Lim JT, Schrieber RD, Schindler

CW and Krolewski JJ (1996) Phosphorylated IFN-a receptor 1 subunit acts as a

125

Page 27: REFERENCES - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/14402/15/15_references.pdf · REFRENCES 9. REFERENCES Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein

REFRENCES

docking site for the latent form of the 113 kDa STAT2 protein. EMBO J., 15:

1064-74

Yee AA, Yin P, Siderovski DP, Mak TW, Litchfield DW and Arrowsmith CH

(1998) Cooperative interaction between the DNA binding domains of PU.1 and

IRF-4. J.Mol. Bioi., 279: 1075-1083.

Yim JH, Wu SJ, Lowney JK, Vander Velde TL and Doherty GM. (1999).

Enhancing in vivo tumorigenicity of B16 melanoma by overexpressing interferon

regulatory factor-2: resistance to endogenous IFN-gamma. J Interferon Cytokine

Res. 19(7): 723-9.

Yoshida K, Yamamoto T, Kohno T, Hironaka N, Yasui K, Kojima C, Mukae H,

Kadota J, Suzuki S, Honma K, Kohno S and Matsuyama T (2005) Active

repression of IRF-1 mediated transactivation by IRF-4. Int. Immunol., 17: 1463-

1471.

Yoneyama M, Suhara W, Fukuhara Y, Fukuda M, Nishida E and Fujita T(1998)

Direct triggering of the type I IFN system by virus infection: activation of

transcription factor complex containing IRF-3 and CBP/p300. EMBO J., 17:

1087-1095.

Zhang L and Pagano JS (1997) A new interferon regulatory factor associated with

Epstein- Barr virus latency. Mol. Cell. Biol. 17: 5748-57

Zhang S, Thomas K, Blanco JC, Salkowski CA and Vogel SN. (2002). The role of

the interferon regulatory factors, IRF-1 and IRF-2, in LPS-induced

cyclooxygenase-2 (COX-2) expression in vivo and in vitro. J Endotoxin Res. 8(5):

379-388.

Zhou Y, Wang S, Gobi A and Oberg K. (2000). The interferon-alpha regulation of

interferon regulatory factor 1 (IRF-1) and IRF-2 has therapeutic implications in

carcinoid tumors. Ann Oncol. 11(6): 707-14.